Company Profile LogoMannKind

MannKind focuses on the discovery and development of therapeutic products for patients with diseases such as diabetes.

Edit IconSuggest an Edit
Pharmaceutical
Health Care
Biotechnology

    Unlock insights on MannKind and 2M+ companies now!

    About MannKind

    MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development, and commercialization of therapeutic products for patients with diseases such as diabetes. Its lead product candidate, AFREZZA(R), is in the late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. It maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKin

    Company Highlights
    Year Founded

    1991

    icon-altEmployees

    561

    Location (HQ)

    USA

    Since Last Funding

    3 years 6 months

    Monthly Website Visitors

    12.0K

    icon-altTotal Investment Amt

    $400M

    Last Funding Round

    Post Ipo Debt

    icon-altMoM Headcount Growth

    -0.36%

    icon-altYoY Headcount Growth

    0.54%

    Key Metrics

    Senior Hires

    NameLinkedin ProfilePositionDate Joined
    John Doehttps://www.linkedin.com/in/johndoeCEOCEO
    Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
    John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
    Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
    Get API access to complete private company database with growth metrics from 15 sources

    Similar Companies

    Health Care

    Biotechnology

    Pharmaceutical

    Pharmaceutical Manufacturing

    Pharmaceuticals